Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-007969
Filing Date
2013-02-13
Accepted
2013-02-13 06:14:28
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v333064_10q.htm 10-Q 383881
2 EXHIBIT 10.1 v333064_ex10-1.htm EX-10.1 27753
3 EXHIBIT 10.2 v333064_ex10-2.htm EX-10.2 217931
4 EXHIBIT 10.3 v333064_ex10-3.htm EX-10.3 23325
5 EXHIBIT 31.1 v333064_ex31-1.htm EX-31.1 10634
6 EXHIBIT 31.2 v333064_ex31-2.htm EX-31.2 10741
7 EXHIBIT 32.1 v333064_ex32-1.htm EX-32.1 6374
  Complete submission text file 0001144204-13-007969.txt   2694216

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cadi-20121231.xml EX-101.INS 251769
9 XBRL TAXONOMY EXTENSION SCHEMA cadi-20121231.xsd EX-101.SCH 32616
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cadi-20121231_cal.xml EX-101.CAL 31151
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cadi-20121231_def.xml EX-101.DEF 103699
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cadi-20121231_lab.xml EX-101.LAB 207580
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cadi-20121231_pre.xml EX-101.PRE 139242
Mailing Address 207 KILEY DRIVE SALISBURY MD 21801
Business Address 207 KILEY DRIVE SALISBURY MD 21801 410-912-3700
Cadista Holdings Inc. (Filer) CIK: 0001521762 (see all company filings)

EIN.: 311259887 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54421 | Film No.: 13599474
SIC: 2834 Pharmaceutical Preparations